Shmagin Martin E 4
4 · Urigen Pharmaceuticals, Inc. · Filed Feb 26, 2009
Insider Transaction Report
Form 4
Urigen Pharmaceuticals, Inc.UGRP.OB
Shmagin Martin E
DirectorChief Financial Officer
Transactions
- Purchase
Common Stock, $.001 Par Value
2009-02-24$0.12/sh+1,000$120→ 3,123,573 total - Purchase
Common Stock, $.001 Par Value
2009-02-25$0.10/sh+1,500$150→ 3,125,073 total - Purchase
Common Stock, $.001 Par Value
2009-02-25$0.12/sh+1,000$120→ 3,126,073 total